newsfilter
← Latest News
GlobeNewswire·

23andMe to Report Q2 FY2025 Financial Results

ME

SUNNYVALE, Calif., Nov. 07, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (NASDAQ:ME) (23andMe), a leading human genetics and biopharmaceutical company, announced today that it will report financial results for the